Tavneos (avacopan) - Amgen
Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
An Unusual Case of Renal-Limited ANCA-Associated Vasculitis: Chasing the Big Vessel (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0779; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "High-dose steroids, plasmapheresis, and cyclophosphamide were initiated. Due to concerns for excessive immunosuppression and hemorrhagic cystitis, she was transitioned to rituximab and avacopan...Her biopsy findings of isolated intimal arteritis without glomerular involvement represent an atypical finding with uncertain prognosis. Ultimately, her course reflected the delicate balance between effective immunosuppression and the heightened risk of infection in vulnerable individuals." 
Clinical • ANCA Vasculitis • Glomerulonephritis • Hematological Disorders • Infectious Disease • Lupus Nephritis • Nephrology • Renal Disease • Septic Shock • Vasculitis • MPO
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559358
 
Ishani Mishra; Girik Bhatia; Huma Fatima; Martha Catalina Morales-Alvarez
 
Oct 2, 2026
 
Prev Next